...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS

"I can't sit around while completely avoidable and unwarranted wealth destruction and human misery continues, unthreatened by a stalled miracle drug Apabetalone.  Sorry, I know too much about this miracle drug, how beneficial it will be to humanity, and how incredibly disruptive it will be in the Big Pharma industry.  "

 

Golf you might have  hit the nall on the head as to why not 1 BP has come  to the table for a major deal with RVX,  Apabetalone might be very disruptive to already revenue  generating  drugs that don't cure issue but rather just  help the health issues.  However Apabetalone might just help extend the patents of some BP drugs in a combo version.  I often wonder maybe then why does Zenith E have so amny collaboration deals with BP's and then I think RVX should have the same and they don't for soem reason....

Share
New Message
Please login to post a reply